About Instituto de Moléstias Cardiovasculares de Tatuí
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
EMS
2
Bayer
1
Eli Lilly and Company
1
Eurofarma Laboratorios S.A.
1
Kowa Research Institute, Inc.
1
Clinical Trials at Instituto de Moléstias Cardiovasculares de Tatuí
During the past decade, Instituto de Moléstias Cardiovasculares de Tatuí conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
2011-08-01
2012-11-01
Unknown status
280
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma
2022-07-22
2023-10-01
Recruiting
134
Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma
2022-07-22
2023-10-01
Recruiting
134
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
2023-02-03
2025-01-08
Recruiting
432
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instituto de Moléstias Cardiovasculares de Tatuí" #1 sponsor was "EMS" with 2 trials, followed by "Bayer" with 1 trials
sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Eurofarma Laboratorios S.A." with 1 trials sponsored and "Kowa Research Institute, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Moléstias Cardiovasculares de Tatuí"
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Instituto de Moléstias Cardiovasculares de Tatuí
According to Clinical.Site data, the most researched conditions in "Instituto de Moléstias Cardiovasculares de Tatuí" are
"Asthma" (2 trials), "Heart Failure" (2 trials), "Arterial Hypertension" (1 trials), "Dyslipidemia" (1 trials) and "Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Instituto de Moléstias Cardiovasculares de Tatuí" in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Moléstias Cardiovasculares de Tatuí
Most popular intervention types in "Instituto de Moléstias Cardiovasculares de Tatuí" are "Drug" (6 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Budesonide / Formoterol 400/12" (1 trials), "Budesonide / Formoterol 400/12 Placebo" (1 trials), "Budesonide/formoterol 200/6" (1 trials) and "Budesonide/formoterol 200/6 placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Moléstias Cardiovasculares de Tatuí
The vast majority of trials in "Instituto de Moléstias Cardiovasculares de Tatuí" are
6 trials for "All" genders.
Clinical Trials Status at Instituto de Moléstias Cardiovasculares de Tatuí
Currently, there are NaN active trials in "Instituto de Moléstias Cardiovasculares de Tatuí".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Instituto de Moléstias Cardiovasculares de Tatuí,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Moléstias Cardiovasculares de Tatuí, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".